
Axelium offers an AI-powered agent that revolutionizes meta-analyses in clinical research and biomedical applications. Their solution provides end-to-end automation for literature search, data extraction, statistical analysis, and report generation, adhering to PRISMA guidelines. The platform is designed to be cost-effective and scalable by optimizing LLM inference, and offers customizable analyses supporting methods like NMA for comparative effectiveness assessment, market access planning, clinical trial design optimization, enhancing regulatory submissions, and clinical practice guidelines. The company targets the healthcare, biotech, pharma, CRO, and market access industries.

Axelium offers an AI-powered agent that revolutionizes meta-analyses in clinical research and biomedical applications. Their solution provides end-to-end automation for literature search, data extraction, statistical analysis, and report generation, adhering to PRISMA guidelines. The platform is designed to be cost-effective and scalable by optimizing LLM inference, and offers customizable analyses supporting methods like NMA for comparative effectiveness assessment, market access planning, clinical trial design optimization, enhancing regulatory submissions, and clinical practice guidelines. The company targets the healthcare, biotech, pharma, CRO, and market access industries.